Physician profile
Julius Tang
NPI 1326332172
$14,349.34
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,546 · 2020: $1,668 · 2021: $46.51 · 2022: $279 · 2023: $9,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $883 · Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $882.63 |
| Food and Beverage | $427.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,142.84 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Abiomed | $625.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $143.16 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $123.83 | 2020 | |
| Getinge USA Sales, LLC | $63.55 | 2019 | |
| Davol INC. | $47.47 | 2019-2020 | |
| Endogastric Solutions, INC | $27.28 | 2023 | Esophyx |
| Olympus America INC. | $26.89 | 2023 | Visera 4k Uhd Camera Control Unit |
| Acell, INC. | $23.58 | 2019 | |
| Janssen Biotech, INC. | $21.36 | 2022 | |
| Elutia, INC. | $21.32 | 2019 | |
| Chiesi USA, INC. | $19.14 | 2019 | |
| Lsi Solutions INC | $18.38 | 2019 | |
| Boston Scientific Corporation | $17.54 | 2020 | |
| Philips North America LLC | $14.78 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $12.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julius Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.